Timothy P Cripe, MD, PhD
College of Medicine
>Cancer ● Neurilemmoma ● Sarcoma, Ewing ● Rhabdomyosarcoma ● Neurofibromatosis 1 ● Neuroblastoma ● Infection ● Sarcoma ● Neurofibroma ● Osteosarcoma
As a member of the Translational Therapeutics Program at the OSUCCC – James, Timothy Cripe, MD, PhD, explores biologics and targeted therapeutic agents for non-central-nervous-system solid tumors in children, especially sarcomas and neuroblastoma.Dr. Cripe’s work is focused on developing oncolytic virotherapy and small-molecule-targeted inhibitors, both in preclinical and early-stage clinical settings. His recent projects include development of a polycarbon cancer therapeutic agent, testing of a new tropomyosin inhibitor and studies of the role of immunomodulators in increasing the effectiveness of virotherapy. Dr. Cripe has co-authored over 100 articles and book chapters. The articles have appeared in well-respected publications such as Journal of Clinical Investigation, Cancer Research, Clinical Cancer Research, Molecular Therapy and Journal of Clinical Oncology.